COVID-19: all 7,774 studies

Page 13 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• Convalescent Plasma Collection and Treatment in Pediatrics and AdultsCompletedNCT04376034Phase 3Results posted
• COVID-19: Human Epidemiology and Response to SARS-CoV-2CompletedNCT04375761Results posted
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary InjuryCompletedNCT04375397Phase 2Results posted
• Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRSCompletedNCT04374149Phase 2Results posted
• Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19CompletedNCT04372628Phase 2Results posted
• Duvelisib to Combat COVID-19CompletedNCT04372602Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 PneumoniaCompletedNCT04372186Phase 3Results posted
• Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 InfectionTerminatedNCT04372017Phase 3Results posted
• Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 InfectionCompletedNCT04371471Results posted
• Tocilizumab for Patients With Cancer and COVID-19 DiseaseTerminatedNCT04370834Phase 2Results posted
• INB03 for the Treatment of Pulmonary Complications From COVID-19TerminatedNCT04370236Phase 2/3Results posted
• Treating COVID-19 With Hydroxychloroquine (TEACH)TerminatedNCT04369742Phase 2Results posted
• Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaTerminatedNCT04369469Phase 3Results posted
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsCompletedNCT04368728Phase 2/3Results posted
• Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 PandemicCompletedNCT04368260Not applicableResults posted
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19CompletedNCT04367831Phase 4Results posted
• Ramipril for the Treatment of COVID-19CompletedNCT04366050Phase 2Results posted
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19TerminatedNCT04365985Phase 2Results posted
• Cardiovascular Effects of COVID-19CompletedNCT04365699Phase 2Results posted
• Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)TerminatedNCT04365257Phase 2Results posted
• Canakinumab in Covid-19 Cardiac Injury (The Three C Study)CompletedNCT04365153Phase 2Results posted
• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
• ARB, ACEi, DRi Effects on COVID-19 Course DiseaseCompletedNCT04364984Results posted
• COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and InpatientsCompletedNCT04364802Phase 2Results posted
• A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)TerminatedNCT04364763Phase 2Results posted
• CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized PatientsCompletedNCT04364737Phase 2Results posted
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 PneumoniaCompletedNCT04363736Phase 2Results posted
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced PneumoniaCompletedNCT04362813Phase 3Results posted
• Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19TerminatedNCT04362189Phase 2Results posted
• Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized AdultsCompletedNCT04362176Phase 3Results posted
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine StormCompletedNCT04362137Phase 3Results posted
• Early Treatment of Cytokine Storm Syndrome in Covid-19CompletedNCT04362111Phase 3Results posted
• Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard CareCompletedNCT04362085Phase 3Results posted
• Covid-19 Associated CoagulopathyCompletedNCT04360824Phase 4Results posted
• Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 PatientsTerminatedNCT04360551Phase 2Results posted
• Plasma Therapy of COVID-19 in Severely Ill PatientsCompletedNCT04359810Phase 2Results posted
• COVID-19 Patient Positioning Pragmatic TrialCompletedNCT04359797Not applicableResults posted
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 InfectionCompletedNCT04359680Phase 3Results posted
• Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)CompletedNCT04359654Phase 2Results posted
• Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19CompletedNCT04358549Phase 2Results posted
• Rhu-pGSN for Severe Covid-19 PneumoniaCompletedNCT04358406Phase 2Results posted
• Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 DiseaseCompletedNCT04358081Phase 3Results posted
• Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19TerminatedNCT04358068Phase 2Results posted
• Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased OxygenationCompletedNCT04357782Phase 1/2Results posted
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 InfectionCompletedNCT04357730Phase 2Results posted
• Etoposide in Patients With COVID-19 InfectionTerminatedNCT04356690Phase 2Results posted
• Convalescent Plasma in Outpatients With COVID-19CompletedNCT04355767Phase 3Results posted
• Use of UC-MSCs for COVID-19 PatientsCompletedNCT04355728Phase 1/2Results posted
• Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)CompletedNCT04355143Phase 2Results posted
• COVID-19 PrEP HCW HCQ StudyCompletedNCT04354870Phase 2Results posted
• Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized PatientsCompletedNCT04354831Phase 2Results posted
• Treatment for COVID-19 in High-Risk Adult OutpatientsTerminatedNCT04354428Phase 2/3Results posted
• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialCompletedNCT04354155Phase 2Results posted
• Stopping ACE-inhibitors in COVID-19CompletedNCT04353596Phase 4Results posted
• Camostat Mesylate in COVID-19 OutpatientsCompletedNCT04353284Phase 2Results posted
• Trial of Hydroxychloroquine In Covid-19 KineticsTerminatedNCT04353271Phase 2/3Results posted
• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)CompletedNCT04351243Phase 2Results posted
• Dapagliflozin in Respiratory Failure in Patients With COVID-19CompletedNCT04350593Phase 3Results posted
• A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19CompletedNCT04349631Phase 2Results posted
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 InfectionCompletedNCT04349098Phase 2Results posted
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)TerminatedNCT04348656Phase 3Results posted
• Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)CompletedNCT04348500Phase 2Results posted
• A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.CompletedNCT04348435Phase 2Results posted
• A Prospective "Universal" Observational Database for COVID-19CompletedNCT04347993Results posted
• PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)CompletedNCT04347954Phase 1/2Results posted
• Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurETerminatedNCT04347941Not applicableResults posted
• Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19CompletedNCT04347538Not applicableResults posted
• Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19CompletedNCT04347239Phase 2Results posted
• Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19TerminatedNCT04347226Phase 2Results posted
• Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19CompletedNCT04346628Phase 2Results posted
• Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental OxygenTerminatedNCT04346615Phase 2/3Results posted
• Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.CompletedNCT04346199Phase 2Results posted
• Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare WorkersCompletedNCT04345653Phase 2Results posted
• A Study of Auxora in Patients With Severe COVID-19 PneumoniaCompletedNCT04345614Phase 2Results posted
• Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)CompletedNCT04345601Phase 1/2Results posted
• Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) InfectionTerminatedNCT04344600Phase 2Results posted
• Convalescent Plasma vs. Standard Plasma for COVID-19TerminatedNCT04344535Phase 1/2Results posted
• A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 InfectionCompletedNCT04343989Phase 2Results posted
• Pegylated Interferon Lambda Treatment for COVID-19TerminatedNCT04343976Phase 2Results posted
• Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 InfectionTerminatedNCT04343755Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19CompletedNCT04343651Phase 2Results posted
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)TerminatedNCT04343248Phase 3Results posted
• Effectiveness of Ivermectin as add-on Therapy in COVID-19 ManagementCompletedNCT04343092Phase 1Results posted
• A Study of LY3127804 in Participants With COVID-19TerminatedNCT04342897Phase 2Results posted
• The Role of Resistant Starch in COVID-19 InfectionTerminatedNCT04342689Phase 2/3Results posted
• A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 InfectionCompletedNCT04342663Phase 2Results posted
• University of Utah COVID-19 Hydrochloroquine TrialCompletedNCT04342169Phase 2Results posted
• Sirolimus Treatment in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04341675Phase 2Results posted
• Will Hydroxychloroquine Impede or Prevent COVID-19TerminatedNCT04341441Phase 3Results posted
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)CompletedNCT04341116Phase 2/3Results posted
• Breath Analysis Based Disease BiomarkersCompletedNCT04341012Results posted
• Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 InfectionCompletedNCT04340557Phase 4Results posted
• COVID-19 Convalescent PlasmaCompletedNCT04340050Early Phase 1Results posted
• Atovaquone and Azithromycin Combination for Confirmed COVID-19 InfectionTerminatedNCT04339426Phase 2Results posted
• TXA and Corona Virus 2019 (COVID19) in OutpatientsTerminatedNCT04338074Phase 2Results posted
• Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019CompletedNCT04338009Not applicableResults posted
• Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19TerminatedNCT04336332Phase 2Results posted
• Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 InfectionTerminatedNCT04335552Phase 2Results posted
• Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together ProgramCompletedNCT04335279Not applicableResults posted
• Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19CompletedNCT04335136Phase 2Results posted

← COVID-19 overview